Search research articles
Contact Us
Filters
Showing results (11-20 of 295) with videos related to
Page
of 30
Sort By:
Current Allergy and Asthma Reports
|
February 3, 2005
The re-emergence of the mast cell as a pivotal cell in asthma pathogenesis
Christopher E Brightling, Peter Bradding
Drugs
|
July 25, 2014
Asthma therapy and its effect on airway remodelling
Rachid Berair, Christopher E Brightling
The Lancet. Respiratory Medicine
|
September 10, 2021
Pathological disease in the lung periphery after acute COVID-19
Salman Siddiqui, Christopher E Brightling
COPD
|
April 24, 2018
Biologic Drugs: A New Target Therapy in COPD?
Ahmed Yousuf, Christopher E Brightling
The Journal of Allergy and Clinical Immunology
|
May 6, 2014
Reply: To PMID 24238646
Sumit Gupta, Christopher E Brightling
Chest
|
October 7, 2015
Is the eosinophil a leading villain in lung function decline?
Christopher E Brightling, Leena George
International Journal of Chronic Obstructive Pulmonary Disease
|
December 1, 2007
Eosinophilic airway inflammation in COPD
Shironjit Saha, Christopher E Brightling
Expert Review of Respiratory Medicine
|
February 1, 2013
Eosinophils as diagnostic tools in chronic lung disease
Osama Eltboli, Christopher E Brightling
Therapeutic Advances in Chronic Disease
|
January 16, 2016
Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease
Leena George, Christopher E Brightling
The European Respiratory Journal
|
January 1, 2022
Bronchial thermoplasty: what we know, what we don't know, and what we need to know
Richard J Russell, Christopher E Brightling
Page
of 30
Search research articles
Search
Showing results (11-20 of 295) with videos related to
Sort By:
Page
of 30
Current Allergy and Asthma Reports
|
February 3, 2005
The re-emergence of the mast cell as a pivotal cell in asthma pathogenesis
Christopher E Brightling, Peter Bradding
Drugs
|
July 25, 2014
Asthma therapy and its effect on airway remodelling
Rachid Berair, Christopher E Brightling
The Lancet. Respiratory Medicine
|
September 10, 2021
Pathological disease in the lung periphery after acute COVID-19
Salman Siddiqui, Christopher E Brightling
COPD
|
April 24, 2018
Biologic Drugs: A New Target Therapy in COPD?
Ahmed Yousuf, Christopher E Brightling
The Journal of Allergy and Clinical Immunology
|
May 6, 2014
Reply: To PMID 24238646
Sumit Gupta, Christopher E Brightling
Chest
|
October 7, 2015
Is the eosinophil a leading villain in lung function decline?
Christopher E Brightling, Leena George
International Journal of Chronic Obstructive Pulmonary Disease
|
December 1, 2007
Eosinophilic airway inflammation in COPD
Shironjit Saha, Christopher E Brightling
Expert Review of Respiratory Medicine
|
February 1, 2013
Eosinophils as diagnostic tools in chronic lung disease
Osama Eltboli, Christopher E Brightling
Therapeutic Advances in Chronic Disease
|
January 16, 2016
Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease
Leena George, Christopher E Brightling
The European Respiratory Journal
|
January 1, 2022
Bronchial thermoplasty: what we know, what we don't know, and what we need to know
Richard J Russell, Christopher E Brightling
Page
of 30